These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 8107289)

  • 1. [Protein C, protein S and heparin cofactor II--their significance as the regulatory factors in the blood coagulation cascade].
    Shinmyozu K
    Rinsho Byori; 1994 Jan; 42(1):9-15. PubMed ID: 8107289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system.
    Dahlbäck B
    Thromb Haemost; 1991 Jul; 66(1):49-61. PubMed ID: 1833851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physiologie and cellular regulation of the protein C system].
    Vincenot A; Gaussem P
    Ann Biol Clin (Paris); 1997; 55(1):17-24. PubMed ID: 9099247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein C.
    Esmon CT
    Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor V and protein S as cofactors to activated protein C.
    Dahlbäck B
    Haematologica; 1997; 82(1):91-5. PubMed ID: 9107093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
    Dahlbäck B
    Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C4b-binding protein inhibits the factor V-dependent but not the factor V-independent cofactor activity of protein S in the activated protein C-mediated inactivation of factor VIIIa.
    van de Poel RH; Meijers JC; Bouma BN
    Thromb Haemost; 2001 May; 85(5):761-5. PubMed ID: 11372664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protein C, protein S].
    Guillin MC; Bezeaud A
    Ann Biol Clin (Paris); 1987; 45(2):184-90. PubMed ID: 3039876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition.
    Dahlbäck B; Villoutreix BO
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1311-20. PubMed ID: 15860736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic cofactor function of factor V and protein S to activated protein C in the inactivation of the factor VIIIa - factor IXa complex -- species specific interactions of components of the protein C anticoagulant system.
    Shen L; He X; Dahlbäck B
    Thromb Haemost; 1997 Sep; 78(3):1030-6. PubMed ID: 9308749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: a possible association with interleukin-6.
    Undar L; Ertuğrul C; Altunbaş H; Akça S
    Thromb Haemost; 1999 Apr; 81(4):571-5. PubMed ID: 10235441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va.
    Van Walderveen MC; Berry LR; Atkinson HM; Chan AK
    Thromb Haemost; 2010 May; 103(5):910-9. PubMed ID: 20216984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The numerous properties of the anticoagulant protein C].
    Cerchiara E; Tirindelli MC; Giannetti B; Dicuonzo G; Avvisati G
    Clin Ter; 2007; 158(2):181-7. PubMed ID: 17566522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of activated protein C and inactivation of cell-bound thrombin by antithrombin III at the surface of cultured vascular endothelial cells--a comparative study of two anticoagulant mechanisms.
    Delvos U; Meusel P; Preissner KT; Müller-Berghaus G
    Thromb Haemost; 1987 Feb; 57(1):87-91. PubMed ID: 3590084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of complex formation and epidermal growth factor-like domains in the regulation of blood coagulation by the thrombomodulin-protein C system.
    Kurosawa S
    Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1343-9. PubMed ID: 2560886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
    Nishioka J; Ido M; Hayashi T; Suzuki K
    Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-protein C interaction.
    Comp PC
    Nouv Rev Fr Hematol (1978); 1984; 26(4):239-42. PubMed ID: 6089102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis.
    Mosnier LO; Meijers JC; Bouma BN
    Thromb Haemost; 2001 Oct; 86(4):1040-6. PubMed ID: 11686322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of heparin cofactor II function by S protein (vitronectin) and formation of a ternary S protein-thrombin-heparin cofactor II complex.
    Preissner KT; Sié P
    Thromb Haemost; 1988 Dec; 60(3):399-406. PubMed ID: 2976993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.